Home > > > Report Detail

Global Seasonal Influenza Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publisher Name :
Date: 13-Jan-2023
No. of pages: 104

Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine.

According to our (Global Info Research) latest study, the global Seasonal Influenza Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The key factor that drives the growth of this market is the increase in incidences of influenza virus globally.

This report is a detailed and comprehensive analysis for global Seasonal Influenza Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Seasonal Influenza Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029

Global Seasonal Influenza Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029

Global Seasonal Influenza Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029

Global Seasonal Influenza Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Seasonal Influenza Vaccines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Seasonal Influenza Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline plc, Sinovac Biotech Ltd, Changsheng Bio-Technology, Ccbio SA and Aleph Biomedical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Seasonal Influenza Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

- Type A (H1N1)

- Type A (H3N2)

- Type B

Market segment by Application

- Pediatrics

- Adolescence

- Adults

- Elderly

Major players covered

- GlaxoSmithKline plc

- Sinovac Biotech Ltd

- Changsheng Bio-Technology

- Ccbio SA

- Aleph Biomedical

- Sanofi

- Jiangsu Simcere Vaxtec Bio-pharmaceutical

- Dalian Hissen Bio-pharm

- Abbott Laboratories

- Novartis International AG

Market segment by region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Seasonal Influenza Vaccines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Seasonal Influenza Vaccines, with price, sales, revenue and global market share of Seasonal Influenza Vaccines from 2018 to 2023.

Chapter 3, the Seasonal Influenza Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Seasonal Influenza Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Seasonal Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Seasonal Influenza Vaccines.

Chapter 14 and 15, to describe Seasonal Influenza Vaccines sales channel, distributors, customers, research findings and conclusion.

Global Seasonal Influenza Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Seasonal Influenza Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Seasonal Influenza Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Type A (H1N1)
1.3.3 Type A (H3N2)
1.3.4 Type B
1.4 Market Analysis by Application
1.4.1 Overview: Global Seasonal Influenza Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pediatrics
1.4.3 Adolescence
1.4.4 Adults
1.4.5 Elderly
1.5 Global Seasonal Influenza Vaccines Market Size & Forecast
1.5.1 Global Seasonal Influenza Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Seasonal Influenza Vaccines Sales Quantity (2018-2029)
1.5.3 Global Seasonal Influenza Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GlaxoSmithKline plc
2.1.1 GlaxoSmithKline plc Details
2.1.2 GlaxoSmithKline plc Major Business
2.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Product and Services
2.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline plc Recent Developments/Updates
2.2 Sinovac Biotech Ltd
2.2.1 Sinovac Biotech Ltd Details
2.2.2 Sinovac Biotech Ltd Major Business
2.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product and Services
2.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sinovac Biotech Ltd Recent Developments/Updates
2.3 Changsheng Bio-Technology
2.3.1 Changsheng Bio-Technology Details
2.3.2 Changsheng Bio-Technology Major Business
2.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Product and Services
2.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Changsheng Bio-Technology Recent Developments/Updates
2.4 Ccbio SA
2.4.1 Ccbio SA Details
2.4.2 Ccbio SA Major Business
2.4.3 Ccbio SA Seasonal Influenza Vaccines Product and Services
2.4.4 Ccbio SA Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ccbio SA Recent Developments/Updates
2.5 Aleph Biomedical
2.5.1 Aleph Biomedical Details
2.5.2 Aleph Biomedical Major Business
2.5.3 Aleph Biomedical Seasonal Influenza Vaccines Product and Services
2.5.4 Aleph Biomedical Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aleph Biomedical Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Seasonal Influenza Vaccines Product and Services
2.6.4 Sanofi Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi Recent Developments/Updates
2.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
2.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Details
2.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Major Business
2.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product and Services
2.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates
2.8 Dalian Hissen Bio-pharm
2.8.1 Dalian Hissen Bio-pharm Details
2.8.2 Dalian Hissen Bio-pharm Major Business
2.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product and Services
2.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Dalian Hissen Bio-pharm Recent Developments/Updates
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business
2.9.3 Abbott Laboratories Seasonal Influenza Vaccines Product and Services
2.9.4 Abbott Laboratories Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Abbott Laboratories Recent Developments/Updates
2.10 Novartis International AG
2.10.1 Novartis International AG Details
2.10.2 Novartis International AG Major Business
2.10.3 Novartis International AG Seasonal Influenza Vaccines Product and Services
2.10.4 Novartis International AG Seasonal Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis International AG Recent Developments/Updates
3 Competitive Environment: Seasonal Influenza Vaccines by Manufacturer
3.1 Global Seasonal Influenza Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Seasonal Influenza Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Seasonal Influenza Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Seasonal Influenza Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Seasonal Influenza Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Seasonal Influenza Vaccines Manufacturer Market Share in 2022
3.5 Seasonal Influenza Vaccines Market: Overall Company Footprint Analysis
3.5.1 Seasonal Influenza Vaccines Market: Region Footprint
3.5.2 Seasonal Influenza Vaccines Market: Company Product Type Footprint
3.5.3 Seasonal Influenza Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Seasonal Influenza Vaccines Market Size by Region
4.1.1 Global Seasonal Influenza Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Seasonal Influenza Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Seasonal Influenza Vaccines Average Price by Region (2018-2029)
4.2 North America Seasonal Influenza Vaccines Consumption Value (2018-2029)
4.3 Europe Seasonal Influenza Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Seasonal Influenza Vaccines Consumption Value (2018-2029)
4.5 South America Seasonal Influenza Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Seasonal Influenza Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Seasonal Influenza Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Seasonal Influenza Vaccines Consumption Value by Type (2018-2029)
5.3 Global Seasonal Influenza Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Seasonal Influenza Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Seasonal Influenza Vaccines Consumption Value by Application (2018-2029)
6.3 Global Seasonal Influenza Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Seasonal Influenza Vaccines Market Size by Country
7.3.1 North America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Seasonal Influenza Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Seasonal Influenza Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Seasonal Influenza Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Seasonal Influenza Vaccines Market Size by Country
8.3.1 Europe Seasonal Influenza Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Seasonal Influenza Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Seasonal Influenza Vaccines Market Size by Region
9.3.1 Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Seasonal Influenza Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Seasonal Influenza Vaccines Market Size by Country
10.3.1 South America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Seasonal Influenza Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Seasonal Influenza Vaccines Market Size by Country
11.3.1 Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Seasonal Influenza Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Seasonal Influenza Vaccines Market Drivers
12.2 Seasonal Influenza Vaccines Market Restraints
12.3 Seasonal Influenza Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Seasonal Influenza Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Seasonal Influenza Vaccines
13.3 Seasonal Influenza Vaccines Production Process
13.4 Seasonal Influenza Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Seasonal Influenza Vaccines Typical Distributors
14.3 Seasonal Influenza Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Seasonal Influenza Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Seasonal Influenza Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline plc Major Business
Table 5. GlaxoSmithKline plc Seasonal Influenza Vaccines Product and Services
Table 6. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlaxoSmithKline plc Recent Developments/Updates
Table 8. Sinovac Biotech Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Sinovac Biotech Ltd Major Business
Table 10. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product and Services
Table 11. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sinovac Biotech Ltd Recent Developments/Updates
Table 13. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 14. Changsheng Bio-Technology Major Business
Table 15. Changsheng Bio-Technology Seasonal Influenza Vaccines Product and Services
Table 16. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Changsheng Bio-Technology Recent Developments/Updates
Table 18. Ccbio SA Basic Information, Manufacturing Base and Competitors
Table 19. Ccbio SA Major Business
Table 20. Ccbio SA Seasonal Influenza Vaccines Product and Services
Table 21. Ccbio SA Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ccbio SA Recent Developments/Updates
Table 23. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
Table 24. Aleph Biomedical Major Business
Table 25. Aleph Biomedical Seasonal Influenza Vaccines Product and Services
Table 26. Aleph Biomedical Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Aleph Biomedical Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi Seasonal Influenza Vaccines Product and Services
Table 31. Sanofi Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanofi Recent Developments/Updates
Table 33. Jiangsu Simcere Vaxtec Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Simcere Vaxtec Bio-pharmaceutical Major Business
Table 35. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product and Services
Table 36. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates
Table 38. Dalian Hissen Bio-pharm Basic Information, Manufacturing Base and Competitors
Table 39. Dalian Hissen Bio-pharm Major Business
Table 40. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product and Services
Table 41. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Dalian Hissen Bio-pharm Recent Developments/Updates
Table 43. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. Abbott Laboratories Major Business
Table 45. Abbott Laboratories Seasonal Influenza Vaccines Product and Services
Table 46. Abbott Laboratories Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Abbott Laboratories Recent Developments/Updates
Table 48. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 49. Novartis International AG Major Business
Table 50. Novartis International AG Seasonal Influenza Vaccines Product and Services
Table 51. Novartis International AG Seasonal Influenza Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novartis International AG Recent Developments/Updates
Table 53. Global Seasonal Influenza Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Seasonal Influenza Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Seasonal Influenza Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Seasonal Influenza Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Seasonal Influenza Vaccines Production Site of Key Manufacturer
Table 58. Seasonal Influenza Vaccines Market: Company Product Type Footprint
Table 59. Seasonal Influenza Vaccines Market: Company Product Application Footprint
Table 60. Seasonal Influenza Vaccines New Market Entrants and Barriers to Market Entry
Table 61. Seasonal Influenza Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Seasonal Influenza Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Seasonal Influenza Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Seasonal Influenza Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Seasonal Influenza Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Seasonal Influenza Vaccines Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Seasonal Influenza Vaccines Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Seasonal Influenza Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Seasonal Influenza Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Seasonal Influenza Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Seasonal Influenza Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Seasonal Influenza Vaccines Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Seasonal Influenza Vaccines Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Seasonal Influenza Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Seasonal Influenza Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Seasonal Influenza Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Seasonal Influenza Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Seasonal Influenza Vaccines Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Seasonal Influenza Vaccines Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Seasonal Influenza Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Seasonal Influenza Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Seasonal Influenza Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Seasonal Influenza Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Seasonal Influenza Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Seasonal Influenza Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Seasonal Influenza Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Seasonal Influenza Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Seasonal Influenza Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Seasonal Influenza Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Seasonal Influenza Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Seasonal Influenza Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Seasonal Influenza Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Seasonal Influenza Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Seasonal Influenza Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Seasonal Influenza Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Seasonal Influenza Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Seasonal Influenza Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Seasonal Influenza Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Seasonal Influenza Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Seasonal Influenza Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Seasonal Influenza Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Seasonal Influenza Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Seasonal Influenza Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Seasonal Influenza Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Seasonal Influenza Vaccines Raw Material
Table 121. Key Manufacturers of Seasonal Influenza Vaccines Raw Materials
Table 122. Seasonal Influenza Vaccines Typical Distributors
Table 123. Seasonal Influenza Vaccines Typical Customers
List of Figures
Figure 1. Seasonal Influenza Vaccines Picture
Figure 2. Global Seasonal Influenza Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Seasonal Influenza Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Type A (H1N1) Examples
Figure 5. Type A (H3N2) Examples
Figure 6. Type B Examples
Figure 7. Global Seasonal Influenza Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Seasonal Influenza Vaccines Consumption Value Market Share by Application in 2022
Figure 9. Pediatrics Examples
Figure 10. Adolescence Examples
Figure 11. Adults Examples
Figure 12. Elderly Examples
Figure 13. Global Seasonal Influenza Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Seasonal Influenza Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Seasonal Influenza Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Seasonal Influenza Vaccines Average Price (2018-2029) & (USD/Unit)
Figure 17. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Seasonal Influenza Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Seasonal Influenza Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Seasonal Influenza Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Seasonal Influenza Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Seasonal Influenza Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Seasonal Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Seasonal Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Seasonal Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Seasonal Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Seasonal Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Seasonal Influenza Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Seasonal Influenza Vaccines Average Price by Type (2018-2029) & (USD/Unit)
Figure 32. Global Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Seasonal Influenza Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Seasonal Influenza Vaccines Average Price by Application (2018-2029) & (USD/Unit)
Figure 35. North America Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Seasonal Influenza Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Seasonal Influenza Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Seasonal Influenza Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Seasonal Influenza Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Seasonal Influenza Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Seasonal Influenza Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 55. China Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Seasonal Influenza Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Seasonal Influenza Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Seasonal Influenza Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Seasonal Influenza Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Seasonal Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Seasonal Influenza Vaccines Market Drivers
Figure 76. Seasonal Influenza Vaccines Market Restraints
Figure 77. Seasonal Influenza Vaccines Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines in 2022
Figure 80. Manufacturing Process Analysis of Seasonal Influenza Vaccines
Figure 81. Seasonal Influenza Vaccines Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs